Strides Pharma debuts with an ESG rating of 76/100 in S&P Global’s CSA 2024
Strides has secured a position in the 94th percentile among its peers in the DRG Global Pharmaceuticals industry
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Strides Pharma Science
Strides gains USFDA approval for Acetaminophen and Ibuprofen Tablets, 125 mg /250 mg
The product is bioequivalent to the reference listed drug (RLD), Advil Dual Action with Acetaminophen, 125 mg /250 mg (OTC), of…
OneSource receives equity commitments of Rs 8,010 Mn at a pre-money equity valuation of $ 1.65 Bn
OneSource is in the process of seeking final approval for the Scheme from NCLT, Mumbai Bench, to thereafter achieve the listing of…
Strides gets USFDA approval for Fluoxetine Tabs 10 mg and 20 mg
Fluoxetine is an antidepressant used for the treatment of MDD, OCD, bulimia nervosa, panic disorder, with or without agoraphobia
Strides gets USFDA approval for Gabapentin Tablets USP, 600 mg and 800 mg
Gabapentin tablets will be manufactured at the company’s facility in Puducherry
Strides gets USFDA approval for generic Suprep Bowel Prep Kit
The product belongs to a group of medicines prescribed to those who are required to undergo a colon cleanse prior to a colonoscopy
Strides gets USFDA approval for Levetiracetam Oral Solution
It is used in the treatment of seizures
Strides gets USFDA approval for Efavirenz, Emtricitabine & Tenofovir Disoproxil Fumurate…
Strides’ ANDA is approved under USFDA’s expedited review provision for the President’s Emergency Plan for AIDS Relief (PEPFAR)
Strides gets USFDA approval for Icosapent Ethyl Capsules
The product complements Strides’ range of approved soft gelatin capsules
Strides gets tentative USFDA nod for Dolutegravir tablets
The PEPFAR tentative approval for Strides qualifies the Company to participate in global donor funded programs that procure this…